![Bruce P. Burnett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bruce P. Burnett
Director Técnico/Científico/I+D en
INFLARX N.V.
.
Perfil
Bruce P.
Burnett currently works at Primus Pharmaceuticals, Inc., as Director-Medical Education & Scientific Affairs and InflaRx NV, as Vice President & Head-Medical Affairs from 2020.
Dr. Burnett also formerly worked at Vitro Biopharma, Inc., as Principal, Sangamo Therapeutics, Inc., as Principal, and Cytokine Sciences, Inc., as Principal.
Dr. Burnett received his undergraduate degree from Eastern Washington University and graduate degree and doctorate degree from Yale University.
Cargos activos de Bruce P. Burnett
| Empresas | Cargo | Inicio |
|---|---|---|
| INFLARX N.V. | Director Técnico/Científico/I+D | 01/01/2020 |
Primus Pharmaceuticals, Inc.
 Primus Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Provides prescription metabolic products to physicians and patients | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Bruce P. Burnett.
| Empresas | Cargo | Fin |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Cytokine Sciences, Inc.
 Cytokine Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biopharmaceutical products that address the role of the blood and vessels | Corporate Officer/Principal | - |
| VITRO DIAGNOSTICS, INC. | Corporate Officer/Principal | - |
Formación de Bruce P. Burnett.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
40
Relaciones de 1er grado
7
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Vitro Biopharma, Inc.
 Vitro Biopharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops cell therapies for autoimmune diseases and inflammatory disorders | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Primus Pharmaceuticals, Inc.
Primus Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Provides prescription metabolic products to physicians and patients | Retail Trade |
Cytokine Sciences, Inc.
Cytokine Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops biopharmaceutical products that address the role of the blood and vessels | Commercial Services |
Eastern Washington University
 Eastern Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InflaRx NV
 InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
- Bolsa de valores
- Insiders
- Bruce P. Burnett
